Bristol Myers Squibb's facility in Devens, MA

Bris­tol My­ers scales up cell ther­a­py pro­duc­tion with liso-cel nod in hand and an­oth­er ap­proval maybe on the way

Af­ter a long-await­ed ap­proval for its CD19 tar­get­ing CAR-T liso-cel, Bris­tol My­ers Squibb is gear­ing up for the loom­ing re­view of an­oth­er cell ther­a­py in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.